The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats

Adam J. Prus, Alan Pehrson, Scott D. Philibin, Jesse T. Wood, Sarah A. Vunck, Joseph H. Porter

Research output: Contribution to journalArticleResearchpeer-review

7 Citations (Scopus)

Abstract

Rationale: The discriminative stimulus properties of clozapine (CLZ) have been studied for decades because it remains the prototype for atypical antipsychotic drug effects and yet is unique in many ways, including increased efficacy in treatment-resistant schizophrenia and in reducing suicidality. Recent studies have indicated that the active CLZ metabolite N-desmethylclozapine (NDMC) may play a role in mediating the cognitive efficacy of CLZ and may also have atypical antipsychotic properties. Objectives: The present study sought to determine if NDMC has discriminative stimulus properties similar to that of its parent drug CLZ. Materials and methods: Rats were trained to discriminate 1.25 mg/kg CLZ from vehicle in a two-choice drug discrimination task. Results: Although NDMC (2.5-20.0 mg/kg) failed to substitute for CLZ, the combination of NDMC (5.0 and 10.0 mg/kg) with a low dose (0.3125 mg/kg) of CLZ produced full substitution (>80% CLZ-appropriate responding) for the 1.25 mg/kg CLZ training dose. Co-administration of the M1-preferring receptor antagonist trihexyphenidyl (6.0 mg/kg) with a 5.0 mg/kg dose of NDMC produced partial substitution (>60% to <80% CLZ-appropriate responding) for CLZ, while administration of trihexyphenidyl alone (0.3-12.0 mg/kg) failed to substitute for CLZ. Conclusions: These findings suggest that NDMC produces discriminative stimulus effects that are different from those elicited by its parent drug CLZ. This difference may be due to the agonist properties of NDMC at M1 muscarinic cholinergic receptors.

Original languageEnglish
Pages (from-to)295-301
Number of pages7
JournalPsychopharmacology
Volume203
Issue number2
DOIs
StatePublished - 1 Apr 2009

Fingerprint

norclozapine
Clozapine
Cholinergic Receptors
Muscarinic Receptors
Antipsychotic Agents
Trihexyphenidyl

Keywords

  • Antipsychotic
  • Cholinergic
  • Clozapine
  • Drug discrimination
  • Muscarinic
  • N-Desmethylclozapine
  • Schizophrenia
  • Trihexyphenidyl

Cite this

Prus, Adam J. ; Pehrson, Alan ; Philibin, Scott D. ; Wood, Jesse T. ; Vunck, Sarah A. ; Porter, Joseph H. / The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats. In: Psychopharmacology. 2009 ; Vol. 203, No. 2. pp. 295-301.
@article{c586135b98344c729a38ccdd3c609121,
title = "The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats",
abstract = "Rationale: The discriminative stimulus properties of clozapine (CLZ) have been studied for decades because it remains the prototype for atypical antipsychotic drug effects and yet is unique in many ways, including increased efficacy in treatment-resistant schizophrenia and in reducing suicidality. Recent studies have indicated that the active CLZ metabolite N-desmethylclozapine (NDMC) may play a role in mediating the cognitive efficacy of CLZ and may also have atypical antipsychotic properties. Objectives: The present study sought to determine if NDMC has discriminative stimulus properties similar to that of its parent drug CLZ. Materials and methods: Rats were trained to discriminate 1.25 mg/kg CLZ from vehicle in a two-choice drug discrimination task. Results: Although NDMC (2.5-20.0 mg/kg) failed to substitute for CLZ, the combination of NDMC (5.0 and 10.0 mg/kg) with a low dose (0.3125 mg/kg) of CLZ produced full substitution (>80{\%} CLZ-appropriate responding) for the 1.25 mg/kg CLZ training dose. Co-administration of the M1-preferring receptor antagonist trihexyphenidyl (6.0 mg/kg) with a 5.0 mg/kg dose of NDMC produced partial substitution (>60{\%} to <80{\%} CLZ-appropriate responding) for CLZ, while administration of trihexyphenidyl alone (0.3-12.0 mg/kg) failed to substitute for CLZ. Conclusions: These findings suggest that NDMC produces discriminative stimulus effects that are different from those elicited by its parent drug CLZ. This difference may be due to the agonist properties of NDMC at M1 muscarinic cholinergic receptors.",
keywords = "Antipsychotic, Cholinergic, Clozapine, Drug discrimination, Muscarinic, N-Desmethylclozapine, Schizophrenia, Trihexyphenidyl",
author = "Prus, {Adam J.} and Alan Pehrson and Philibin, {Scott D.} and Wood, {Jesse T.} and Vunck, {Sarah A.} and Porter, {Joseph H.}",
year = "2009",
month = "4",
day = "1",
doi = "10.1007/s00213-008-1262-0",
language = "English",
volume = "203",
pages = "295--301",
journal = "Psychopharmacology",
issn = "0033-3158",
publisher = "Springer Verlag",
number = "2",

}

The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats. / Prus, Adam J.; Pehrson, Alan; Philibin, Scott D.; Wood, Jesse T.; Vunck, Sarah A.; Porter, Joseph H.

In: Psychopharmacology, Vol. 203, No. 2, 01.04.2009, p. 295-301.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - The role of M1 muscarinic cholinergic receptors in the discriminative stimulus properties of N-desmethylclozapine and the atypical antipsychotic drug clozapine in rats

AU - Prus, Adam J.

AU - Pehrson, Alan

AU - Philibin, Scott D.

AU - Wood, Jesse T.

AU - Vunck, Sarah A.

AU - Porter, Joseph H.

PY - 2009/4/1

Y1 - 2009/4/1

N2 - Rationale: The discriminative stimulus properties of clozapine (CLZ) have been studied for decades because it remains the prototype for atypical antipsychotic drug effects and yet is unique in many ways, including increased efficacy in treatment-resistant schizophrenia and in reducing suicidality. Recent studies have indicated that the active CLZ metabolite N-desmethylclozapine (NDMC) may play a role in mediating the cognitive efficacy of CLZ and may also have atypical antipsychotic properties. Objectives: The present study sought to determine if NDMC has discriminative stimulus properties similar to that of its parent drug CLZ. Materials and methods: Rats were trained to discriminate 1.25 mg/kg CLZ from vehicle in a two-choice drug discrimination task. Results: Although NDMC (2.5-20.0 mg/kg) failed to substitute for CLZ, the combination of NDMC (5.0 and 10.0 mg/kg) with a low dose (0.3125 mg/kg) of CLZ produced full substitution (>80% CLZ-appropriate responding) for the 1.25 mg/kg CLZ training dose. Co-administration of the M1-preferring receptor antagonist trihexyphenidyl (6.0 mg/kg) with a 5.0 mg/kg dose of NDMC produced partial substitution (>60% to <80% CLZ-appropriate responding) for CLZ, while administration of trihexyphenidyl alone (0.3-12.0 mg/kg) failed to substitute for CLZ. Conclusions: These findings suggest that NDMC produces discriminative stimulus effects that are different from those elicited by its parent drug CLZ. This difference may be due to the agonist properties of NDMC at M1 muscarinic cholinergic receptors.

AB - Rationale: The discriminative stimulus properties of clozapine (CLZ) have been studied for decades because it remains the prototype for atypical antipsychotic drug effects and yet is unique in many ways, including increased efficacy in treatment-resistant schizophrenia and in reducing suicidality. Recent studies have indicated that the active CLZ metabolite N-desmethylclozapine (NDMC) may play a role in mediating the cognitive efficacy of CLZ and may also have atypical antipsychotic properties. Objectives: The present study sought to determine if NDMC has discriminative stimulus properties similar to that of its parent drug CLZ. Materials and methods: Rats were trained to discriminate 1.25 mg/kg CLZ from vehicle in a two-choice drug discrimination task. Results: Although NDMC (2.5-20.0 mg/kg) failed to substitute for CLZ, the combination of NDMC (5.0 and 10.0 mg/kg) with a low dose (0.3125 mg/kg) of CLZ produced full substitution (>80% CLZ-appropriate responding) for the 1.25 mg/kg CLZ training dose. Co-administration of the M1-preferring receptor antagonist trihexyphenidyl (6.0 mg/kg) with a 5.0 mg/kg dose of NDMC produced partial substitution (>60% to <80% CLZ-appropriate responding) for CLZ, while administration of trihexyphenidyl alone (0.3-12.0 mg/kg) failed to substitute for CLZ. Conclusions: These findings suggest that NDMC produces discriminative stimulus effects that are different from those elicited by its parent drug CLZ. This difference may be due to the agonist properties of NDMC at M1 muscarinic cholinergic receptors.

KW - Antipsychotic

KW - Cholinergic

KW - Clozapine

KW - Drug discrimination

KW - Muscarinic

KW - N-Desmethylclozapine

KW - Schizophrenia

KW - Trihexyphenidyl

UR - http://www.scopus.com/inward/record.url?scp=62449286272&partnerID=8YFLogxK

U2 - 10.1007/s00213-008-1262-0

DO - 10.1007/s00213-008-1262-0

M3 - Article

VL - 203

SP - 295

EP - 301

JO - Psychopharmacology

JF - Psychopharmacology

SN - 0033-3158

IS - 2

ER -